Fibrinogen/trombine (Fibrin glue)
Generic name
Fibrinogen/trombine (Fibrin glue)
Brand name
ATC Code
B02BC30
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Wound stitching |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
VITAMIN K AND OTHER HEMOSTATICS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Vitamin K | ||
|---|---|---|
| B02BA01 | ||
| Fibrinogen | ||
|---|---|---|
| B02BB01 | ||
| Blood coagulation factors | ||
|---|---|---|
| B02BD08 | ||
| B02BD04 | ||
| B02BD02 | ||
| B02BD01 | ||
| Other systemic hemostatics | ||
|---|---|---|
| B02BX05 | ||
| B02BX06 | ||
| B02BX04 | ||
| Blood coagulation factors | ||
|---|---|---|
| B02BD08 | ||
| B02BD04 | ||
| B02BD02 | ||
| B02BD01 | ||
Reference
- Corza Medical GmbH, SmPC TachoSil (EU/1/04/277/001-005) Rev 25, 12-05-2023, www.ema.europa.eu
Changes
Therapeutic Drug Monitoring
Overdose
